Cognition Therapeutics’ Alzheimer’s Disease Candidate CT1812 Meets Phase 1b/2a Study Objectives: Well Tolerated with Positive Influence on Biomarkers of Synapse Recovery
Press Release, November 4th, 2017
PLSG awarded $500K grant for health information technology
Pittsburgh Business Times, October 3rd, 2017
Carmell Therapeutics closes $4M Series B round of funding
Press Release, July 11th, 2017
PLSG closes second fund at $5.2M
Pittsburgh Business Times, May 31st, 2017
Rinovum Inks Deals with Target, Large Pharma Firm
, May 22nd, 2017
Wellbridge Healthcare, Diamond Healthcare Corp. Add Texas Hospital to Network
D CEO Healthcare, May 19th, 2017
Carmell Therapeutics to move into new manufacturing facility
Pittsburgh Business Times, May 9th, 2017
Gateway Health and Wellbridge Health Announce Partnership to Provide Healthcare Innovative Solutions to Gateway Membership
Pittsburgh Business Times, March 31st, 2017